Carriage of Neisseria Meningitidis in 2 - 29 Years Old in Mali, Senegal and The Gambia
This poster, presented at the 16th International Pathogenic Neisseria Conference in the Netherlands, discusses a study that aimed to provide preliminary information regarding meningococcal carriage in West Africa and on the effect on carriage of MenAfriVac, a novel tetanus toxoid conjugate Neisseria meningitidis serogroup A vaccine. The authors concluded that study results revealed substantial serogroup hetherogenicity between countries. They also noted that serogroup A isolates were nearly absent, so no conclusion on the impact of MenAfrivac conjugate vaccine in these study populations could be drawn.
Author(s): Caugant DA, Tamboura B, Tapia M, et al.
Download file (English)
113 KB PDF (Located at www.meningvax.org)
Citation: Caugant DA, Tamboura B, Tapia M, et al. Carriage of Neisseria Meningitidis in 2 - 29 Years Old in Mali, Senegal and The Gambia. Presented at: 16th International Pathogenic Neisseria Conference, September 7 to 12, 2008; Rotterdam, Netherlands.